Under the fresh terms of their strategic alliance, Serum Life Sciences will make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma, a wholly-owned subsidiary of Biocon, into equity in BBL.
Bank stocks lead market recovery as Nifty closes above 25,000
On Monday, market indices Sensex and Nifty showed a recovery following heavy intraday losses. Investors reacted positively to gains in banking stocks driven by foreign